Generic Drugs - The Pay-for-Delay Problem (Hardcover, New)

Brand-name pharmaceutical companies can delay generic competition that lowers prices by agreeing to pay a generic competitor to hold its competing product off the market for a certain period of time. These so-called "pay-for-delay" agreements have arisen as part of patent litigation settlement agreements between brand-name and generic pharmaceutical companies. "Pay-for-delay" agreements are "win-win" for the companies: brand name pharmaceutical prices stay high, and the brand and generic share the benefits of the brand's monopoly profits. Consumers lose, however: they miss out on generic prices that can be as much as 90 percent less than brand prices. For example, brand-name medication that costs $300 per month, might be sold as a generic for as little as $30 per month. This book examines the "pay-for-delay' program and how drug company pay-offs cost consumers billions.

General

Imprint:	nova science publishers
Country of origin:	United States
Release date:	February 2011
First published:	March 2011
Editors:	Christina M. Curtin
Dimensions:	155 x 230 x 13mm (L x W x T)
Format:	Hardcover
Pages:	126
Edition:	New
ISBN-13:	978-1-61122-071-1
Categories:	Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries Books > Medicine > General issues > Public health & preventive medicine > General Promotions
LSN:	1-61122-071-8
Barcode:	9781611220711

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!